Health AI built for wealthy systems tends to answer the question “how do we make an overloaded clinician slightly faster?” That is a real problem. It is not the problem most of the world has.
What the path actually looks like
In much of South Asia the doctor does not hand you your results. The doctor orders a test, you go to a laboratory yourself, you pay for it yourself, and a few days later a PDF arrives on your phone. The follow-up appointment may be weeks away, or may never happen, because it costs money and time that the test already consumed.
So the document sits on a phone, unread, during exactly the period when the person is most worried about it. That gap is not an inconvenience in the system. For a very large number of people it is the system.
What this changes about the product
- The patient is the user, not the clinician. There is often no clinician in the loop at the moment of need.
- The laboratory is the distribution point. It is the institution standing at the start of the gap, with the document and the relationship.
- Price sensitivity is absolute. A subscription priced for a different economy is not a bad deal, it is an impossible one.
- Language is not a feature. It is the condition of the product working at all.
Why medicines matter more than tests here
Out-of-pocket health spending in these markets is dominated by medicines, not by diagnostics. A product that only reads laboratory reports is addressing the smaller share of what people actually spend on and worry about. Reading a prescription, and explaining what each medicine on it is for, sits much closer to where the money and the anxiety actually are.
This article explains how our technology works. It is health information, not medical advice.